Skip to main content
Top
Published in: Critical Care 2/2014

Open Access 01-04-2014 | Poster presentation

Inhibitory effects of evodiamine on zymosan-induced inflammation: inactivation of NF-κB by inhibiting IκBα phosphorylation

Authors: X Fan, J-y Zhu, Z Liu, J Yan, Q Ma, H-p Liang

Published in: Critical Care | Special Issue 2/2014

Login to get access

Excerpt

Inflammation is a host defense reaction against pathogenic infection. In this process, inflammatory cytokines contribute to combat against infection, but excess cytokines will lead to tissue damage. Nonsteroidal anti-inflammatory drugs and corticosteroids are commonly used for regulating these inflammatory mediators and treatment of inflammatory disorders. But these drugs are not sufficient for clinical practice due to their adverse effects, so new anti-inflammatory drugs are still needed. Evodiamine (EVO), an important alkaloidal component extracted from the fruit of Evodiae fructus, possesses the property of analgesia, antiemesis, and vascular dilatation. Its anti-inflammatory effect and underlying mechanism were investigated using a zymosan-induced inflammatory model. …
Metadata
Title
Inhibitory effects of evodiamine on zymosan-induced inflammation: inactivation of NF-κB by inhibiting IκBα phosphorylation
Authors
X Fan
J-y Zhu
Z Liu
J Yan
Q Ma
H-p Liang
Publication date
01-04-2014
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 2/2014
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc14014

Other articles of this Special Issue 2/2014

Critical Care 2/2014 Go to the issue